Kent A. Robertson

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial”.

Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Nature Medicine(2021)10.1038/s41591-020-01193-6

N/A

2.0DataRank · unranked

96 citations

Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi +25 more

Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1

Pediatric Blood & Cancer(2020)10.1002/pbc.28372

N/A

0DataRank · unranked

5 citations

Steven D. Rhodes, Abbi E. Smith, Shi Chen, Waylan Bessler, Michael J. Ferguson +10 more